Latest On Oncolytics Biotech Inc (ONCY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-26 14:43 EST | News | Oncolytics falls 16% after mid-stage data for breast cancer therapy | N/A |  |
| 2023-05-05 17:10 EST | News | Oncolytics Biotech Inc. (ONCY) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-05 17:10 EST | News | Oncolytics Biotech GAAP EPS of -$0.10 in-line | N/A | |
| 2023-05-04 15:09 EST | News | Oncolytics Biotech Q1 2023 Earnings Preview | N/A | |
| 2023-03-04 00:55 EST | News | Oncolytics Biotech Inc. (ONCY) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-03 10:12 EST | News | Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.07 | N/A | |
| 2022-12-01 15:27 EST | News | Oncolytics stock rises on FDA fast track tag for pelareorep to treat pancreatic cancer | N/A | |
| 2022-11-07 22:47 EST | News | Oncolytics Biotech GAAP EPS of -C$0.08 in-line | N/A | |
| 2022-11-07 22:46 EST | News | Oncolytics Biotech, Inc. (ONCY) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 23:54 EST | News | Oncolytics Biotech Q3 2022 Earnings Preview | N/A | |
| 2022-08-12 06:06 EST | News | Oncolytics Biotech Inc. (ONCY) CEO Matthew Coffey on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 13:32 EST | News | Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 | N/A | |
| 2022-08-10 21:28 EST | News | Oncolytics Biotech Q2 2022 Earnings Preview | N/A | |
| 2022-05-06 06:02 EST | News | Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.01 | N/A | |
| 2022-05-06 06:02 EST | News | Oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-05 07:14 EST | News | Oncolytics Biotech Q1 2022 Earnings Preview | N/A | |
| 2022-03-31 14:53 EST | News | Oncolytics Biotech stock rises 11% on positive safety data from colorectal cancer therapy | N/A | |
| 2022-03-04 09:13 EST | News | Oncolytics Biotech GAAP EPS of -C$0.14 | N/A | |
| 2022-03-04 09:13 EST | News | Oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-02 22:44 EST | News | Oncolytics reports positive safety data in phase 1/2 pancreatic cancer group | N/A | |
| 2022-01-20 23:20 EST | News | Oncolytics rises 7% amid enrollment update on phase 1/2 gastrointestinal cancer study | N/A | |
| 2021-12-10 19:56 EST | News | Oncolytics Biotech jumps 9% on positive data for breast cancer candidate | N/A | |
| 2021-11-06 06:17 EST | News | Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-05 11:05 EST | News | Oncolytics Biotech reports Q3 results | N/A | |
| 2021-11-05 11:05 EST | News | Oncolytics rises premarket after Q3 2021 earnings beat, breast cancer data | N/A | |
| 2021-11-04 13:58 EST | News | Oncolytics Biotech Q3 2021 Earnings Preview | N/A | |
| 2021-11-03 16:43 EST | News | Oncolytics Biotech gets dosing underway in phase 1/2 pelareorep/atezolizumab cancer trial | N/A | |
| 2021-10-14 22:52 EST | News | Oncolytics partner doses first patient in Chinese trial of pelareorep combo in breast cancer | N/A | |
| 2021-10-12 10:56 EST | News | Warning: ONCY is at high risk of performing badly | N/A | |
| 2021-10-06 14:17 EST | News | ONCY is at high risk of performing badly | N/A | |
| 2021-09-27 23:18 EST | News | Warning: ONCY has been downgraded to Very Bearish | N/A | |
| 2021-09-23 09:09 EST | News | Warning: ONCY has been downgraded to Very Bearish. | N/A | |
| 2021-08-07 04:31 EST | News | Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-06 08:08 EST | News | Oncolytics Biotech EPS misses by $0.03 | N/A | |
| 2021-05-07 13:04 EST | News | Oncolytics Biotech reports Q1 results | N/A | |
| 2021-04-07 01:14 EST | News | Our First Look At Oncolytics Biotech | N/A | |
| 2021-03-08 12:15 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-06 00:06 EST | News | Oncolytics Biotech EPS misses by C$0.12 | N/A | |
| 2021-03-06 00:06 EST | News | Oncolytics Biotech secures $80M capital raise | N/A | |
| 2021-03-06 00:04 EST | News | Oncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-23 18:41 EST | News | Oncolytics surges on encouraging pelareorep + CAR T data in solid tumors | N/A | |
| 2020-11-26 21:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 04:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-15 12:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 01:54 EST | News | Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 00:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-31 23:13 EST | News | Oncolytics Bio teams up with Roche in gastrointestinal cancer trial | N/A | |
| 2020-09-26 13:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:44 EST | Financials | Company financials have been released. | Neutral | |
About Oncolytics Biotech Inc (ONCY):
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
General
- Name Oncolytics Biotech Inc
- Symbol ONCY
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 25
- Last Split Factor10:95
- Last Split Date2018-05-25
- Fiscal Year EndDecember
- IPO Date1999-11-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.oncolyticsbiotech.com
View More
Valuation
- Price/Book (Most Recent Quarter) 8.32
View More
Financials
- Most Recent Quarter 2020-12-31
- Return on Assets -59%
- Return on Equity -183%
- Earnings Per Share -$0.83
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 157.62 million
- Book Value Per Share $0.40
View More
Share Statistics
- Shares Outstanding 43.3 million
- Shares Float 51.19 million
- % Held by Insiders 124%
- % Held by Institutions 1.85%
- Shares Short 891018
- Shares Short Prior Month 828747
- Short Ratio 0.36
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.93
- 52 Week High $4.19
- 52 Week Low $1.06
- 50 Day Moving Average 3
- 200 Day Moving Average 2.46
View More
Dividends
- Dividend Date 2018-05-25
- ExDividend Date N/A
- Dividend Yield 0%
View More
Oncolytics Biotech Inc (ONCY) Dividend Calendar:
ONCY's last dividend payment was made to shareholders on May 25, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Oncolytics Biotech Inc (ONCY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-05 | $N/A | -$0.17 | -$0.12 | -45.81% |
| 2020-09-30 | 2020-11-11 | $N/A | -$0.12 | -$0.10 | -21.91% |
| 2020-06-30 | 2020-08-04 | $N/A | -$0.13 | -$0.11 | -20.95% |
| 2020-03-31 | 2020-05-08 | $N/A | $0.03 | -$0.14 | 121.01% |
| 2019-12-31 | 2020-03-05 | $N/A | -$0.62 | -$0.11 | -456.38% |
| 2019-09-30 | 2019-11-12 | $N/A | -$0.12 | -$0.17 | 27.26% |
| 2019-06-30 | 2019-08-13 | $N/A | -$0.20 | -$0.19 | -3.36% |
| 2019-03-31 | 2019-05-03 | $N/A | -$0.20 | -$0.22 | 10.58% |
| 2018-12-31 | 2019-03-08 | $N/A | -$0.21 | -$0.16 | -31.32% |
| 2018-09-30 | 2018-11-12 | $N/A | -$0.15 | -$0.18 | 15.92% |
| 2018-06-30 | 2018-08-03 | $N/A | -$0.21 | -$0.22 | 6.6% |
| 2018-03-31 | 2018-05-11 | $N/A | -$0.22 | -$0.15 | -50.24% |
| 2017-12-31 | 2018-03-09 | $N/A | -$0.30 | -$0.24 | -26.06% |
| 2017-09-30 | 2017-11-08 | $N/A | -$0.15 | -$0.24 | 36.52% |
| 2017-06-30 | 2017-08-03 | $N/A | -$0.23 | -$0.21 | -6.64% |
| 2017-03-31 | 2017-05-05 | $N/A | -$0.21 | -$0.21 | 1.74% |
| 2016-12-31 | 2017-03-10 | $N/A | -$0.35 | -$0.22 | -61.44% |
| 2016-09-30 | 2016-11-03 | $N/A | -$0.21 | -$0.22 | 3.62% |
| 2016-06-30 | 2016-08-04 | $N/A | -$0.15 | -$0.21 | 32.07% |
| 2016-03-31 | 2016-05-06 | $N/A | -$0.22 | -$0.31 | 28.46% |
| 2015-12-31 | 2016-03-11 | $N/A | -$0.22 | -$0.28 | 24.22% |
| 2015-09-30 | 2015-11-05 | $N/A | -$0.02 | -$0.04 | 50% |
| 2015-06-30 | 2015-08-06 | $N/A | -$0.03 | -$0.04 | 25% |
| 2015-03-31 | 2015-05-07 | $N/A | -$0.04 | -$0.04 | 0% |
| 2014-12-31 | 2015-03-16 | $N/A | -$0.04 | -$0.06 | 33.33% |
| 2014-09-30 | 2014-11-06 | $N/A | -$0.05 | -$0.06 | 16.67% |
| 2014-06-30 | 2014-08-07 | $N/A | -$0.47 | -$0.66 | 28.79% |
| 2014-03-31 | 2014-05-08 | $N/A | -$0.57 | -$0.66 | 13.64% |
| 2013-12-31 | 2014-03-13 | $N/A | -$0.66 | -$0.81 | 18.52% |
| 2013-09-30 | 2013-11-07 | $N/A | -$0.66 | -$0.66 | 0% |
| 2013-06-30 | 2013-08-01 | $N/A | -$0.57 | -$0.87 | 34.48% |
| 2013-03-31 | 2013-05-09 | $N/A | -$0.76 | -$0.85 | 10.59% |
| 2012-12-31 | 2013-03-14 | $N/A | -$1.04 | -$1.05 | 0.95% |
| 2012-09-30 | 2012-11-08 | $N/A | -$1.14 | -$1.07 | -6.54% |
| 2012-06-30 | 2012-08-02 | $N/A | -$1.24 | -$1.13 | -9.73% |
| 2012-03-31 | 2012-05-10 | $N/A | -$1.04 | -$1.23 | 15.45% |
| 2011-12-31 | 2012-03-15 | $N/A | -$1.52 | -$0.96 | -58.33% |
| 2011-09-30 | 2011-11-10 | $N/A | -$0.85 | -$1.01 | 15.84% |
| 2011-06-30 | 2011-07-28 | $N/A | -$0.85 | -$0.89 | 4.49% |
| 2011-03-31 | 2011-05-12 | $N/A | -$0.57 | -$0.82 | 30.49% |
| 2010-12-31 | 2011-03-17 | $N/A | -$1.14 | -$0.89 | -28.09% |
| 2010-09-30 | 2010-11-10 | $N/A | -$0.66 | -$0.86 | 23.26% |
| 2010-06-30 | 2010-07-29 | $N/A | -$0.66 | -$0.85 | 22.35% |
| 2010-03-31 | 2010-05-12 | $N/A | -$0.66 | -$0.85 | 22.35% |
| 2009-12-31 | 2010-03-09 | $N/A | -$0.85 | -$0.55 | -54.55% |
| 2009-09-30 | 2009-11-05 | $N/A | -$0.47 | -$0.68 | 30.88% |
| 2009-06-30 | 2009-07-29 | $N/A | -$0.76 | -$0.73 | -4.11% |
| 2009-03-31 | 2009-05-05 | $N/A | -$0.85 | -$1.01 | 15.84% |
| 2008-12-31 | 2009-03-04 | $N/A | -$0.85 | -$1.05 | 19.05% |
| 2008-09-30 | 2008-11-04 | $N/A | -$0.95 | -$1.01 | 5.94% |
| 2008-06-30 | 2008-07-29 | $N/A | -$1.24 | -$0.99 | -25.25% |
| 2008-03-31 | 2008-04-30 | $N/A | -$0.76 | -$1.04 | 26.92% |
| 2007-12-31 | 2008-03-06 | $N/A | -$0.85 | -$0.95 | 10.53% |
| 2007-09-30 | 2007-10-30 | $N/A | -$0.83 | ||
| 2007-06-30 | 2007-07-27 | $N/A | -$0.77 | ||
| 2007-03-31 | 2007-04-27 | $N/A | -$0.87 | ||
| 2006-12-31 | 2007-03-02 | $N/A | -$1.12 | ||
| 2006-09-30 | 2006-11-03 | $N/A | -$0.80 | ||
| 2006-06-30 | 2006-07-26 | $N/A | -$0.70 | ||
| 2006-03-31 | 2006-04-26 | $N/A | -$0.68 | ||
| 2005-12-31 | 2006-03-03 | $N/A | -$0.97 | ||
| 2005-09-30 | 2005-10-26 | $N/A | -$0.85 | -$0.85 | 0% |
| 2005-06-30 | 2005-07-27 | $N/A | -$0.69 | ||
| 2005-03-31 | 2005-04-27 | $N/A | -$0.57 | ||
| 2004-12-31 | 2005-02-15 | $N/A | -$1.52 | -$0.95 | -60% |
| 2004-09-30 | 2004-10-26 | $N/A | -$0.76 | ||
| 2004-06-30 | 2004-08-05 | $N/A | -$0.77 | ||
| 2004-03-31 | 2004-04-27 | $N/A | -$0.71 | ||
| 2003-12-31 | 2004-03-08 | $N/A | -$0.43 | ||
| 2003-09-30 | 2003-11-03 | $N/A | -$0.50 | ||
| 2003-06-30 | 2003-08-05 | $N/A | -$1.19 | ||
| 2003-03-31 | 2003-03-31 | $N/A | -$0.32 | ||
| 2002-06-30 | 2002-06-30 | $N/A | -$0.40 |
Oncolytics Biotech Inc (ONCY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 3.85 million | N/A | N/A | 2.81 million |
| Income Before Tax | N/A | -6.75 million | N/A | N/A | -19.4 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 4.13 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | -6.21 million | N/A | N/A | -6.94 million |
| Operating Income | N/A | -6.32 million | N/A | N/A | -6.94 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | -446085 | N/A | N/A | -12.46 million |
| Net Income From Continuing Operations | N/A | -6.75 million | N/A | N/A | -19.4 million |
| Net Income Applicable to Common Shares | -9.33 million | N/A | -6.83 million | 399662 | -19.4 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -15556 | -3034 | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | -1.9 million | N/A |
| Total Cash Flow from Investing Activities | N/A | -3034 | -10715 | -1245 | N/A |
| Net Borrowings | N/A | -119634 | -113474 | -112625 | -112070 |
| Total Cash Flow from Financial Activities | 3.48 million | 6.61 million | N/A | 9.44 million | 4.45 million |
| Change to Operating Activities | N/A | -1.03 million | 699737 | 516012 | -1.49 million |
| Change in Cash | -2.66 million | 348875 | N/A | 1.85 million | 22912 |
| Total Cash from Operating Activities | -6.12 million | -6.26 million | -3.96 million | -7.25 million | -4.52 million |
| Depreciation | 109769 | 114717 | N/A | 115183 | 115005 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | 160556 | N/A |
| Change to Net Income | N/A | 1.48 million | -5.17 million | 13.42 million | 387839 |
| Capital Expenditures | 15556 | 3034 | N/A | 1245 | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 10.27 million | N/A | N/A | 19.77 million |
| Total Stockholder Equity | N/A | 20.97 million | N/A | N/A | -107894 |
| Other Current Liabilities | 655213 | 745597 | N/A | N/A | 9.36 million |
| Total Assets | N/A | 31.24 million | N/A | N/A | 19.66 million |
| Common Stock | 356.82 million | N/A | 341.15 million | 333.79 million | 311.08 million |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -367.11 million | -357.78 million | -351.03 million | -344.21 million | -344.61 million |
| Other Liabilities | 6.73 million | N/A | 6.73 million | 6.73 million | 6.73 million |
| Other Assets | N/A | N/A | N/A | N/A | N/A |
| Cash | N/A | 26.71 million | N/A | N/A | 14.15 million |
| Total Current Liabilities | 2.71 million | 3.36 million | N/A | N/A | 12.87 million |
| Other Stockholder Equity | 4.02 million | N/A | 4.23 million | 4.38 million | 4.08 million |
| Property, Plant & Equipment | 609132 | N/A | 526118 | 647484 | 727481 |
| Total Current Assets | 33.74 million | 30.52 million | N/A | N/A | 18.93 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 24.75 million | N/A | 23.99 million | 23.43 million | -107894 |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 1.81 million | N/A | N/A | N/A | 3.17 million |
Oncolytics Biotech Inc (ONCY) Chart:
Oncolytics Biotech Inc (ONCY) News:
Below you will find a list of latest news for Oncolytics Biotech Inc (ONCY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Oncolytics Biotech Inc (ONCY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest ONCY Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:06 PM EST | 100 | $0.9649 |
| Jun 13, 2022 7:39 PM EST | 100 | $0.9499 |
Oncolytics Biotech Inc (ONCY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000043/0001129928-20-000043-index.htm |
| 2020-01-03 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920000915/0001104659-20-000915-index.htm |
| 2020-03-09 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920030320/0001104659-20-030320-index.htm |
| 2020-04-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920048027/0001104659-20-048027-index.htm |
| 2020-06-08 | F-10 | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1129928/000110465920070925/0001104659-20-070925-index.htm |
| 2020-06-08 | F-X | Appointment of Agent for Service of Process and Undertaking | https://www.sec.gov/Archives/edgar/data/1129928/000110465920070932/0001104659-20-070932-index.htm |
| 2020-06-12 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1129928/000110465920072747/0001104659-20-072747-index.htm |
| 2020-06-16 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920073470/0001104659-20-073470-index.htm |
| 2020-06-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920073481/0001104659-20-073481-index.htm |
| 2020-06-25 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920076534/0001104659-20-076534-index.htm |
| 2020-06-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000110465920076538/0001104659-20-076538-index.htm |
| 2018-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000039/0001129928-18-000039-index.htm |
| 2018-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000041/0001129928-18-000041-index.htm |
| 2018-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000044/0001129928-18-000044-index.htm |
| 2018-08-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000047/0001129928-18-000047-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000049/0001129928-18-000049-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000051/0001129928-18-000051-index.htm |
| 2018-09-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000053/0001129928-18-000053-index.htm |
| 2018-09-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000055/0001129928-18-000055-index.htm |
| 2018-10-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000057/0001129928-18-000057-index.htm |
| 2018-10-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000059/0001129928-18-000059-index.htm |
| 2018-10-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000061/0001129928-18-000061-index.htm |
| 2018-10-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000063/0001129928-18-000063-index.htm |
| 2018-10-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000065/0001129928-18-000065-index.htm |
| 2018-10-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000067/0001129928-18-000067-index.htm |
| 2018-10-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000069/0001129928-18-000069-index.htm |
| 2018-11-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000071/0001129928-18-000071-index.htm |
| 2018-11-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000073/0001129928-18-000073-index.htm |
| 2018-11-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000075/0001129928-18-000075-index.htm |
| 2018-11-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000079/0001129928-18-000079-index.htm |
| 2018-11-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000081/0001129928-18-000081-index.htm |
| 2018-11-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000083/0001129928-18-000083-index.htm |
| 2018-11-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000086/0001129928-18-000086-index.htm |
| 2018-11-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000088/0001129928-18-000088-index.htm |
| 2018-12-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000090/0001129928-18-000090-index.htm |
| 2018-12-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992818000092/0001129928-18-000092-index.htm |
| 2019-02-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000002/0001129928-19-000002-index.htm |
| 2019-02-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000004/0001129928-19-000004-index.htm |
| 2019-02-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000006/0001129928-19-000006-index.htm |
| 2019-03-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000010/0001129928-19-000010-index.htm |
| 2019-03-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000011/0001129928-19-000011-index.htm |
| 2019-03-15 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000014/0001129928-19-000014-index.htm |
| 2019-03-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000019/0001129928-19-000019-index.htm |
| 2019-03-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000020/0001129928-19-000020-index.htm |
| 2019-04-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000022/0001129928-19-000022-index.htm |
| 2019-04-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000025/0001129928-19-000025-index.htm |
| 2019-05-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000027/0001129928-19-000027-index.htm |
| 2019-05-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000029/0001129928-19-000029-index.htm |
| 2019-05-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000031/0001129928-19-000031-index.htm |
| 2019-05-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000033/0001129928-19-000033-index.htm |
| 2019-06-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000035/0001129928-19-000035-index.htm |
| 2019-07-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000037/0001129928-19-000037-index.htm |
| 2019-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000044/0001129928-19-000044-index.htm |
| 2019-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000046/0001129928-19-000046-index.htm |
| 2019-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000048/0001129928-19-000048-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000050/0001129928-19-000050-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000052/0001129928-19-000052-index.htm |
| 2019-08-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000054/0001129928-19-000054-index.htm |
| 2019-09-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000056/0001129928-19-000056-index.htm |
| 2019-09-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000058/0001129928-19-000058-index.htm |
| 2019-10-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000060/0001129928-19-000060-index.htm |
| 2019-10-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000062/0001129928-19-000062-index.htm |
| 2019-10-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000064/0001129928-19-000064-index.htm |
| 2019-10-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000066/0001129928-19-000066-index.htm |
| 2019-11-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000068/0001129928-19-000068-index.htm |
| 2019-11-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000070/0001129928-19-000070-index.htm |
| 2019-11-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000072/0001129928-19-000072-index.htm |
| 2019-11-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000075/0001129928-19-000075-index.htm |
| 2019-11-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000077/0001129928-19-000077-index.htm |
| 2019-11-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000078/0001129928-19-000078-index.htm |
| 2019-12-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000080/0001129928-19-000080-index.htm |
| 2019-12-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992819000082/0001129928-19-000082-index.htm |
| 2020-01-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000002/0001129928-20-000002-index.htm |
| 2020-01-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000004/0001129928-20-000004-index.htm |
| 2020-01-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000006/0001129928-20-000006-index.htm |
| 2020-03-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000008/0001129928-20-000008-index.htm |
| 2020-03-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000010/0001129928-20-000010-index.htm |
| 2020-03-06 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000012/0001129928-20-000012-index.htm |
| 2020-03-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000014/0001129928-20-000014-index.htm |
| 2020-04-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000016/0001129928-20-000016-index.htm |
| 2020-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000018/0001129928-20-000018-index.htm |
| 2020-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000020/0001129928-20-000020-index.htm |
| 2020-05-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000022/0001129928-20-000022-index.htm |
| 2020-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000024/0001129928-20-000024-index.htm |
| 2020-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000026/0001129928-20-000026-index.htm |
| 2020-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000028/0001129928-20-000028-index.htm |
| 2020-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000030/0001129928-20-000030-index.htm |
| 2020-05-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000032/0001129928-20-000032-index.htm |
| 2020-05-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000034/0001129928-20-000034-index.htm |
| 2020-06-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000036/0001129928-20-000036-index.htm |
| 2020-06-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000039/0001129928-20-000039-index.htm |
| 2020-06-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000041/0001129928-20-000041-index.htm |
| 2020-06-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000043/0001129928-20-000043-index.htm |
| 2020-08-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000046/0001129928-20-000046-index.htm |
| 2020-08-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000048/0001129928-20-000048-index.htm |
| 2020-08-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000050/0001129928-20-000050-index.htm |
| 2020-10-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000054/0001129928-20-000054-index.htm |
| 2020-10-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000112992820000056/0001129928-20-000056-index.htm |
| 2018-04-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418022333/0001144204-18-022333-index.htm |
| 2018-04-25 | F-10 | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1129928/000114420418022351/0001144204-18-022351-index.htm |
| 2018-04-25 | F-X | Appointment of Agent for Service of Process and Undertaking | https://www.sec.gov/Archives/edgar/data/1129928/000114420418022373/0001144204-18-022373-index.htm |
| 2018-05-04 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1129928/000114420418025445/0001144204-18-025445-index.htm |
| 2018-05-31 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418032024/0001144204-18-032024-index.htm |
| 2018-05-31 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418032054/0001144204-18-032054-index.htm |
| 2018-06-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418032457/0001144204-18-032457-index.htm |
| 2018-06-01 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418032461/0001144204-18-032461-index.htm |
| 2018-09-28 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418051362/0001144204-18-051362-index.htm |
| 2018-09-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418051371/0001144204-18-051371-index.htm |
| 2018-10-25 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418055208/0001144204-18-055208-index.htm |
| 2018-10-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000114420418055216/0001144204-18-055216-index.htm |
| 2019-08-13 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420419039632/0001144204-19-039632-index.htm |
| 2019-08-14 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420419040143/0001144204-19-040143-index.htm |
| 2019-08-16 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1129928/000114420419040329/0001144204-19-040329-index.htm |
| 2019-08-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000114420419040344/0001144204-19-040344-index.htm |
| 2018-05-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000127956918001056/0001279569-18-001056-index.htm |
| 2018-05-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000127956918001180/0001279569-18-001180-index.htm |
| 2018-05-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000127956918001202/0001279569-18-001202-index.htm |
| 2018-06-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000127956918001208/0001279569-18-001208-index.htm |
| 2018-06-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1129928/000127956918001246/0001279569-18-001246-index.htm |
| 2018-05-31 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1129928/000135445718000174/0001354457-18-000174-index.htm |
| 2018-05-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1129928/999999999518001161/9999999995-18-001161-index.htm |
| 2020-06-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1129928/999999999520001434/9999999995-20-001434-index.htm |
| 2018-06-05 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1129928/999999999718006164/9999999997-18-006164-index.htm |